ERGIC Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of ERGIC monoclonal antibodies for studying the endoplasmic reticulum-Golgi intermediate compartment (ERGIC). ERGIC monoclonal antibodies are effective tools in various research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The ERGIC plays a crucial role in the transport and processing of proteins between the endoplasmic reticulum and the Golgi apparatus, making it essential for maintaining cellular homeostasis and protein trafficking. Understanding the function of the ERGIC is vital for elucidating mechanisms underlying various diseases, including neurodegenerative disorders and cancer. The study of ERGIC proteins can provide insights into cellular communication and the regulation of secretory pathways. Research focused on ERGIC has revealed significant implications for understanding protein transport mechanisms and cellular organization. Investigating ERGIC components helps scientists better understand fundamental cellular processes and their relationship to human health and disease. ERGIC research continues to unveil new aspects of intracellular transport and protein processing. Santa Cruz Biotechnology monoclonal antibodies for ERGIC research support scientists worldwide in advancing our understanding of cellular transport mechanisms and disease pathways.